US Patent

US10028858 — Intrauterine systems, IUD insertion devices, and related methods and kits therefor

Method of Use · Assigned to Medicines360 · Expires 2034-03-22 · 8y remaining

Vulnerability score 45/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects intrauterine systems, insertion devices, and related methods and kits for inserting an intrauterine device into a female patient's cervix.

USPTO Abstract

Intrauterine systems and components thereof. The systems include an intrauterine device (IUD), an insertion device or applicator for inserting the IUD into the cervix of a female patient. The insertion device includes an elongated sheath; an elongated inner member positioned within a lumen of the elongated sheath; a handle with one or more elongated guides; and a moveable sheath slider. Additionally, methods related to the insertion procedure, and methods of manufacture for the insertion device.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

CodeDescriptionDrug
U-2348 — Jadelle

Patent Metadata

Patent number
US10028858
Jurisdiction
US
Classification
Method of Use
Expires
2034-03-22
Drug substance claim
No
Drug product claim
Yes
Assignee
Medicines360
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.